Skip to main content
SpringerLink
Log in

Examining perceived cancer risk among patients with neurofibromatosis type 1

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Neurofibromatosis 1 (NF1) is a genetic disorder in which patients are at significantly increased risk for developing malignant peripheral nerve sheath tumors (MPNST) and malignant gliomas (brain cancer). We sought to develop a measure for assessing perceived risk of developing MPNST and brain cancer among patients with NF1 and to examine patients’ perceived risk of developing these cancers. We assessed 112 NF1 patients’ perceived risk of developing MPNST and brain cancer using an 8-item scale we developed that yielded two subscales in a principal component analysis (PCA). Linear regression models examined factors associated with perceived risk of malignancy. 33.9 % and 47.3 % of patients disagreed that having NF1 placed them at increased risk for MPNST and brain cancer, respectively. The PCA of the perceived risk items yielded a 2-factor solution with an MPNST and a brain subscale (total scale α = 0.90). Level of anxiety was the primary factor associated with perceived risk for both cancers. A significant proportion of NF1 patients underestimate their risk of developing MPNST and brain cancer. Perceived risk was associated with emotional distress, in particular anxiety. Clinicians should actively communicate with NF1 patients about their elevated cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Poyhonen M, Kytola S, Leisti J (2000) Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland. J Med Genet 37:632–636

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138–143

    Article  CAS  PubMed  Google Scholar 

  3. Riccardi VM, Powell PP (1989) Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis. Neurofibromatosis 2:152–165

    CAS  PubMed  Google Scholar 

  4. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311–314

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. McCaughan JA, Holloway SM, Davidson R, Lam WWK (2007) Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1. J Med Genet 44:463–466

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20:E1–E7

    Article  PubMed  Google Scholar 

  7. Gutmann DH, Rasmussen SA, Wolkenstein P, MacCollin MM, Guha A, Inskip PD, North KN, Poyhonen M, Birch PH, Friedman JM (2002) Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology 59:759–761

    Article  CAS  PubMed  Google Scholar 

  8. Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D (2006) A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95:233–238

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68:1110–1118

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Katapodi MC, Dodd MJ, Lee KA, Facione NC (2009) Underestimation of breast cancer risk: influence on screening behavior. Oncol Nurs Forum 36:306–314

    Article  PubMed  Google Scholar 

  11. Katapodi MC, Lee KA, Facione NC, Dodd MJ (2004) Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38:388–402

    Article  PubMed  Google Scholar 

  12. Stark JR, Bertone-Johnson ER, Costanza ME, Stoddard AM (2006) Factors associated with colorectal cancer risk perception: the role of polyps and family history. Health Educ Res 21:740–749

    Article  PubMed  Google Scholar 

  13. Ritvo P, Irvine J, Robinson G, Brown L, Murphy KJ, Matthew A, Rosen B (2002) Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations. Gynecol Oncol 84:72–80

    Article  CAS  PubMed  Google Scholar 

  14. McCaul KD, Branstetter AD, Schroeder DM, Glasgow RE (1996) What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol 15:423–429

    Article  CAS  PubMed  Google Scholar 

  15. McDowell ME, Occhipinti S, Gardiner RA, Baade PD, Steginga SK (2009) A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. Eur J Cancer Care (Engl) 18:545–555

    Article  CAS  Google Scholar 

  16. Dillard AJ, Couper MP, Zikmund-Fisher BJ (2010) Perceived risk of cancer and patient reports of participation in decisions about screening: the DECISIONS study. Med Decis Making 30:96S–105S

    Article  PubMed  Google Scholar 

  17. Buster KJ, You Z, Fouad M, Elmets C (2012) Skin cancer risk perceptions: a comparison across ethnicity, age, education, gender, and income. J Am Acad Dermatol 66:771–779

    Article  PubMed Central  PubMed  Google Scholar 

  18. Kwak MS, Choi KS, Park S, Park EC (2009) Perceived risk for gastric cancer among the general Korean population: a population-based survey. Psychooncology 18:708–715

    Article  PubMed  Google Scholar 

  19. Wang DL, Smith KB, Esparza S, Leigh FA, Muzikansky A, Park ER, Plotkin SR (2012) Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med 14:977–982

    Article  PubMed Central  PubMed  Google Scholar 

  20. Smith KB, Wang DL, Plotkin SR, Park ER (2013) Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness. Psychooncology. 22(12):2711–2719

    Article  PubMed  Google Scholar 

  21. Park ER, Ostroff JS, Rakowski W, Gareen IF, Diefenbach MA, Feibelmann S, Rigotti NA (2009) Risk perceptions among participants undergoing lung cancer screening: baseline results from the National Lung Screening Trial. Ann Behav Med 37:268–279

    Article  PubMed Central  PubMed  Google Scholar 

  22. Koblitz AR, Kaufman AR, Park E, Klein WMP, Ferrer RA (2013) Lung cancer-related risk perceptions in the National Lung Screening Trial: reliability and prediction over time. Paper presented at the 34th Annual Meeting of the Society of Behavioral Medicine, San Francisco, CA

  23. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401

    Article  Google Scholar 

  24. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396

    Article  CAS  PubMed  Google Scholar 

  25. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs AG (1983) Manual for the State-Trait Anxiety Inventory

  26. Hagger MS, Orbell S (2003) A meta-analytic review of the common-sense model of illness representations. Psychol Health 18:141–184

    Article  Google Scholar 

  27. Hay J, Coups E, Ford J (2006) Predictors of perceived risk for colon cancer in a national probability sample in the United States. J Health Commun 11(Suppl 1):71–92

    Article  PubMed  Google Scholar 

  28. Bjorvatn C, Eide GE, Hanestad BR, Oyen N, Havik OE, Carlsson A, Berglund G (2007) Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. J Genet Couns 16:211–222

    Article  PubMed  Google Scholar 

  29. Lobb EA, Butow PN, Barratt A, Meiser B, Gaff C, Young MA, Haan E, Suthers G, Gattas M, Tucker K (2004) Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes. Br J Cancer 90:321–327

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Rantala J, Platten U, Lindgren G, Nilsson B, Arver B, Lindblom A, Brandberg Y (2009) Risk perception after genetic counseling in patients with increased risk of cancer. Hered Cancer Clin Pract 7:15

    Article  PubMed Central  PubMed  Google Scholar 

  31. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S (2004) Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst 96:122–133

    Article  PubMed  Google Scholar 

  32. Tilburt JC, James KM, Sinicrope PS, Eton DT, Costello BA, Carey J, Lane MA, Ehlers SL, Erwin PJ, Nowakowski KE, Murad MH (2011) Factors influencing cancer risk perception in high risk populations: a systematic review. Hered Cancer Clin Pract 19(9):2

    Article  Google Scholar 

  33. De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288–1292

    Article  PubMed Central  PubMed  Google Scholar 

  34. Tucker T, Wolkenstein P, Revuz J, Zeller J, Friedman JM (2005) Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 65:205–211

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Mongan Institute for Health Policy, Benson-Henry Institute for Mind-Body Medicine, Cancer Center, Massachusetts General Hospital/Harvard Medical School, 50 Staniford St, 907, Boston, MA, 02114, USA

    Elyse R. Park, Kelly B. Smith & Ana-Maria Vranceanu

  2. Department of Neurology and Cancer Center, Massachusetts General Hospital/Harvard Medical School, Boston, USA

    Vanessa L. Merker, Daphne L. Wang & Scott R. Plotkin

  3. Biostatistics Division, Massachusetts General Hospital/Harvard Medical School, Boston, USA

    Alona Muzikansky

Authors
  1. Elyse R. Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kelly B. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vanessa L. Merker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alona Muzikansky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana-Maria Vranceanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daphne L. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Scott R. Plotkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elyse R. Park.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, E.R., Smith, K.B., Merker, V.L. et al. Examining perceived cancer risk among patients with neurofibromatosis type 1. J Neurooncol 122, 127–133 (2015). https://doi.org/10.1007/s11060-014-1689-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-014-1689-6

Keywords

Search

Navigation